CoChat

Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer

Lindén, Mårten, Lind, Sara Bergström, Mayrhofer, Corina, Segersten, Ulrika, Wester, Kenneth, Lyutvinskiy, Yaroslav, Zubarev, Roman, Malmström, Per‐Uno, Pettersson, Ulf · 2012 · PROTEOMICS
Cited by 97

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Nonmuscle invasive tumors of the bladder often recur and thereby bladder cancer patients need regular re‐examinations which are invasive, unpleasant, and expensive. A noninvasive and less expensive method, e.g. a urine dipstick test, for monitoring recurrence would thus be advantageous. In this study, the complementary techniques mass spectrometry (MS) and Western blotting (WB)/dot blot (DB) were used to screen the urine samples from bladder cancer patients. High resolving MS was used to analyze and quantify the urinary proteome and 29 proteins had a significantly higher abundance (p<0.05) in bladder cancer samples compared with control urine samples. The increased abundance found in urine from bladder cancer patients compared with controls was confirmed with Western blot for four selected proteins; fibrinogen β chain precursor, apolipoprotein E, α‐1‐antitrypsin, and leucine‐rich α‐2‐glycoprotein 1. Dot blot analysis of an independent urine sample set pointed out fibrinogen β chain and α‐1‐antitrypsin as most interesting biomarkers having sensitivity and specificity values in the range of 66–85%. Exploring the Human Protein Atlas (HPA) also revealed that bladder cancer tumors are the likely source of these proteins. They have the potential of being useful in diagnosis, monitoring of recurrence and thus may improve the treatment of bladder tumors, especially nonmuscle invasive tumors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/pmic.201000810

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 97

Metadata

Authors
Lindén, M., Lind, S. B., Mayrhofer, C., Segersten, U., Wester, K., Lyutvinskiy, Y., Zubarev, R., Malmström, P., & Pettersson, U.
Venue
PROTEOMICS
Publisher
Wiley
Published
2011-12-02
Volume
12
Issue
1
Pages
135-144
ISSN
  • 1615-9853 (ISSN-L)
  • 1615-9861
OpenAlex
W2153861174
Cited by
97
References
2
FWCI
7.83
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer. https://app.cochat.ai/papers/10.1002/pmic.201000810
The paper
Lindén, M., Lind, S. B., Mayrhofer, C., Segersten, U., Wester, K., Lyutvinskiy, Y., Zubarev, R., Malmström, P., & Pettersson, U. (2012). Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer. PROTEOMICS. https://doi.org/10.1002/pmic.201000810

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.